There has been an update on the status of the Olmesartan Products Resolution Program. There were approximately 8,000 Claim Packages submitted for consideration in August 2018. After the Claims Administrator completed their adjudication of each claim, hundreds of Claimants appealed their Rejection and Points Award Notices to the Eligibility Committee, which is comprised equally of […]